Immunome Inc (IMNM)

Dec 21, 2024

Immunome, Inc. (NASDAQ:IMNM) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 21, 2024

Dec 21, 2024

Immunome, Inc. (NASDAQ:IMNM) Receives Average Rating of "Buy" from Analysts - MarketBeat

Dec 21, 2024

Dec 19, 2024

Immunome, Inc. (NASDAQ:IMNM) Shares Acquired by Wellington Management Group LLP - Defense World

Dec 19, 2024

Dec 18, 2024

Immunome, Inc. (NASDAQ:IMNM) Sees Significant Decrease in Short Interest - Defense World

Dec 18, 2024

Dec 16, 2024

Immunome, Inc. (NASDAQ:IMNM) Short Interest Update - MarketBeat

Dec 16, 2024

Dec 15, 2024

Long Term Trading Analysis for (IMNM) - Stock Traders Daily

Dec 15, 2024

Dec 12, 2024

Immunome, Inc. (NASDAQ:IMNM) Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Dec 12, 2024

Dec 12, 2024

Charles Schwab Investment Management Inc. Grows Position in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Dec 12, 2024

Dec 11, 2024

Immunome: A Recently Acquired Lead Asset And A Small Market (NASDAQ:IMNM) - Seeking Alpha

Dec 11, 2024

Dec 09, 2024

The Manufacturers Life Insurance Company Sells 1,437 Shares of Immunome, Inc. (NASDAQ:IMNM) - Defense World

Dec 09, 2024

Dec 07, 2024

Intech Investment Management LLC Takes $219,000 Position in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Dec 07, 2024

Dec 06, 2024

Janus Henderson Group PLC Purchases 324,614 Shares of Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Dec 06, 2024

Dec 06, 2024

Cerity Partners LLC Has $776,000 Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Dec 06, 2024

Dec 04, 2024

Where are the Opportunities in (IMNM) - Stock Traders Daily

Dec 04, 2024

Dec 02, 2024

Immunome Grants Stock Options to 15 New Hires in Workforce Expansion - StockTitan

Dec 02, 2024

Dec 02, 2024

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Dec 02, 2024

Nov 27, 2024

Immunome to Present at the Piper Sandler 36th Annual Healthcare Conference - The Bakersfield Californian

Nov 27, 2024

Nov 27, 2024

President of Immunome Picks Up 24% More Stock - Simply Wall St

Nov 27, 2024

Nov 26, 2024

Why Is Immunome Inc (NASDAQ: IMNM) Gaining? - Stocks Register

Nov 26, 2024

Nov 26, 2024

Immunome, Inc. (NASDAQ:IMNM) Receives Average Rating of “Buy” from Analysts - Defense World

Nov 26, 2024

Nov 26, 2024

Immunome, Inc. (NASDAQ:IMNM) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Nov 26, 2024

Nov 26, 2024

Immunome (NASDAQ:IMNM) Shares Gap Up on Insider Buying Activity - Defense World

Nov 26, 2024

Nov 25, 2024

Immunome's chief medical officer Robert Lechleider buys $149,799 in stock - Investing.com India

Nov 25, 2024

Nov 25, 2024

Immunome's chief medical officer Robert Lechleider buys $149,799 in stock By Investing.com - Investing.com Australia

Nov 25, 2024

Nov 25, 2024

Immunome Inc (IMNM) CEO Clay Siegall Increases Stake with Signif - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

Insider Buying: Robert Lechleider Acquires Shares of Immunome In - GuruFocus.com

Nov 25, 2024

Nov 25, 2024

Immunome, Inc. (NASDAQ:IMNM) CTO Acquires $198,030.00 in Stock - MarketBeat

Nov 25, 2024

Nov 25, 2024

Insider Buying: Immunome, Inc. (NASDAQ:IMNM) CEO Purchases 66,057 Shares of Stock - MarketBeat

Nov 25, 2024

Nov 25, 2024

Immunome, Inc. (NASDAQ:IMNM) Insider Acquires $149,831.40 in Stock - MarketBeat

Nov 25, 2024

Nov 25, 2024

Philip Tsai, CTO of Immunome, buys $198,030 in company stock By Investing.com - Investing.com South Africa

Nov 25, 2024

Nov 25, 2024

Philip Tsai, CTO of Immunome, buys $198,030 in company stock - Investing.com India

Nov 25, 2024

Nov 25, 2024

Immunome CEO Clay Siegall acquires $962,181 in company stock By Investing.com - Investing.com Nigeria

Nov 25, 2024

Nov 25, 2024

Immunome CEO Clay Siegall acquires $962,181 in company stock - Investing.com India

Nov 25, 2024

Nov 23, 2024

(IMNM) Investment Analysis and Advice - Stock Traders Daily

Nov 23, 2024

Nov 22, 2024

Immunome files to sell 1.8M shares of common stock for holders - TipRanks

Nov 22, 2024

Nov 21, 2024

Victory Capital Management Inc. Boosts Holdings in Immunome, Inc. (NASDAQ:IMNM) - Defense World

Nov 21, 2024

Nov 21, 2024

Victory Capital Management Inc. Grows Position in Immunome, Inc. (NASDAQ:IMNM) - MarketBeat

Nov 21, 2024

Nov 18, 2024

Leerink Partnrs Decreases Earnings Estimates for Immunome - MarketBeat

Nov 18, 2024

Nov 18, 2024

Wedbush Has Bullish Outlook for Immunome FY2024 Earnings - MarketBeat

Nov 18, 2024

Nov 18, 2024

FY2024 EPS Estimates for Immunome Lowered by Leerink Partnrs - Defense World

Nov 18, 2024

Nov 16, 2024

Immunome Inc. Announces Third Quarter 2024 Financial Results and Pipeline Progress - Defense World

Nov 16, 2024

Nov 15, 2024

Stephens & Co. Initiates Coverage of Immunome (IMNM) with Overweight Recommendation - MSN

Nov 15, 2024

Nov 15, 2024

Immunome Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

Immunome (NASDAQ:IMNM) Stock Price Down 7% After Analyst Downgrade - Defense World

Nov 15, 2024

Nov 14, 2024

T. Rowe Price Investment Management, Inc. Expands Stake in Immun - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Piper Sandler maintains overweight on IMNM with $21 target By Investing.com - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Piper Sandler maintains overweight on IMNM with $21 target - Investing.com India

Nov 14, 2024

Nov 14, 2024

Immunome Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace

Nov 14, 2024

Nov 14, 2024

Janus Henderson Group's Strategic Acquisition of Immunome Inc Sh - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Immunome (NASDAQ:IMNM) Shares Down 7% Following Analyst Downgrade - MarketBeat

Nov 14, 2024

Nov 14, 2024

Piper Sandler Cuts Immunome (NASDAQ:IMNM) Price Target to $21.00 - MarketBeat

Nov 14, 2024

Nov 14, 2024

Immunome price target lowered to $21 from $23 at Piper Sandler - TipRanks

Nov 14, 2024